Bidding 2025 Farewell
As 2025 comes to a close, Lifeline® Cell Technology is reflecting on a year growth, collaboration, and continued innovation. The global community of researchers using our primary cells and cell…
As 2025 comes to a close, Lifeline® Cell Technology is reflecting on a year growth, collaboration, and continued innovation. The global community of researchers using our primary cells and cell…
We’re excited to announce that Lifeline Cell Technology will be exhibiting at Cell Bio 2025, the premier annual gathering of the cell-biology community hosted by the American Society for Cell Biology (ASCB) and European…
As biotechnology advances, the standards for scientific tools grow higher. Researchers depend on solutions that are not only consistent and reliable but specifically designed to meet the exacting demands of…
Obtaining high-quality primary cells is only half the equation for experimental success. Equally important is the use of optimized cell culture media that can preserve the biological and functional integrity…
The end of the year is fast-approaching and it’s time for the final edition of the Life blog! Here at Lifeline® Cell Technology, 2024 marked a year of transformation as…
Here at Lifeline Cell Technology, we’re constantly striving for innovation, not just in our high-quality cell lines and optimized media, but also in the way we present them. We’re excited…
In the fast-evolving world of biotechnology, researchers require tools that offer precision, reliability, and consistency. One of the most critical components in any cell biology research is the cell culture…
Quality, consistency, and reproducibility are all hallmarks of successful cell culture that help researchers derive insights into cellular behavior that advance our understanding of biological development to enable the investigation…
2023 has been an exceptional year for scientific advancements, marked by significant progress in the field of COVID-19 research and the availability of multiple vaccines. The remarkable speed at which…
2021 has been a monumental year for science with the landmark approvals of not one, but two COVID-19 vaccines in the US with many other candidates in the clinical pipeline.…
The rapid spread of COVID-19 during the global pandemic has led many scientists and researchers to look towards repurposing existing FDA-approved drugs, outside the scope of their originally designated purposes,…
Since the emergence of the COVID-19 pandemic, the impact of the virus on the heart has become more pervasive prompting the Journal of the American College of Cardiology to issue…
2020 was a year of uncertainty and unprecedented change brought on by the emergence of the SARS-CoV-2 virus and COVID-19 disease, which has impacted the lives of so many people…
Semi-Annual Review — Lifeline Products Featured in 2020 As 2020 is winding down, we thought it would be worthwhile to look back at the publications that we have highlighted on…
Human umbilical vein endothelial cells (HUVECs) are a widely used source of primary endothelial cells. First isolated in the 1970s, HUVECs are a popular tool for researchers due to their…
A Recap of Lifeline® Products in 2019 It’s that time of year again! As you are winding down 2019 and preparing for 2020, don’t forget to check out the Lifeline®…
Lifeline® Products in Research Studies in First Half of 2019 It’s that time again! Time for our mid-year review, where we look back on the last six months and review…
Research Studies Using Lifeline Cells: 2018 Review
Lifeline® Cells in 2017 It’s the end of the year again and here on the Lifeline® Cell Technology blog you have been keeping up with the various ways researchers from…
Halfway through 2017, here’s a recap of how researchers are using Lifeline® cells to study different disease mechanisms and biological processes. Lifeline® cells are being used to: engineer in vitro…